A look back at some of the more interesting stories from the junior market this past week.
Share Talk Bulletin Board Heroes, Friday 8th November 2019
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update.
Share Talk Bulletin Board Heroes, Monday 4th November 2019
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update.
Share Talk Bulletin Board Heroes, Friday 1st November 2019
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update.
Share Talk Bulletin Board Heroes, Tuesday 15th October 2019
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update.
Small cap movers from the junior market over the past week
A look back at some of the major stories from London’s junior market this week.
Share Talk Bulletin Board Heroes, Friday 11th October 2019
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update.
Faron Pharmaceuticals Ltd (LON:FARN) UK CTA approval
Substantial immune activation taking place post-Clevegen administration UK CTA approval
Share Talk Bulletin Board Heroes, Wednesday 5th December 2018
A charting look at some of the most followed stocks on the London market, Zak Mir covers.
Faron Pharma. Oy (LON:FARN) Patient subgroup identified from INTEREST trial
Dr Markku Jalkanen, CEO of Faron, said: “We have, and are continuing to build, a solid body of evidence which indicates that there is clearly a subgroup of patients for
Faron Pharmaceuticals Ltd (LON: FARN) Notice of Interim Results
TURKU – FINLAND, 8 August 2018 – Faron Pharmaceuticals Ltd (“Faron”) (AIM: FARN), the clinical stage biopharmaceutical company, will be announcing its interim results for the six months ended 30
